UTILIZAREA MEZOPROGESTINELOR ÎN TERAPIA DE SUBSTITUŢIE HORMONALĂ
Price not visible for this package
Interest:
Assignment
Publication info:
No.: RO122180
Date: 27.02.2009
Inventor(s):
ELGER WALTER [DE]
CHWALISZ KRISTOF [DE]
SCHUBERT GERD [DE]
Applicant(s):
JENAPHARM GMBH [DE]
Classification:
International patent classification (IPC):
A61K31/00; A61K31/565; A61K45/00; A61P5/30
Cooperative patent classification (CPC):
A61K31/565 (EP, KR); A61P15/00 (EP); A61P15/12 (EP); A61P5/00 (EP); A61P5/24 (EP); A61P5/30 (EP); A61P5/34 (EP)
Application info:
No.: RO20020000230
Date:
31.08.2000
Priority number(s):
US19990386140
31.08.1999
; WO2000US23771
31.08.2000
Related patents:
AR025456; ATE413168; AU3633201; AU781836; BG106443; BG65846; BR0013710; CA2383659; CN1454088; CO5200773; CZ2002706; CZ301412; EA007840; EA200200285; EE200200102; EP1605924; ES2316402; HRP20020266; HU0202460; IL148417; JP2003513908; KR100729311; KR20020027618; LT2002037; LT5011; LV12942; MXPA02002190; NO20021000; NZ517469; PE20010581; PL198798; PL353931; RS50396; SI20851; SK287121; SK2972002; UA75339; WO0134126; YU14102; ZA200201621
Description:
Prezenta invenţie se referă la utilizarea mezoprogestinelor pentru fabricarea unui medicament administrat în terapia de substituţie hormonală, acesta având atât activitate de agonist, cât şiantagonist faţă de receptorul de progesteron (PR).